This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1087054707308503v1 11/6/711    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Adler, L. A. Articles by Biederman, J. Search for Related Content PubMed PubMed Citation Articles by Adler, L. A. Articles by Biederman, J. Social Bookmarking                         What's this?

The Reliability and Validity of Self and Investigator Ratings of ADHD in Adults

¹ New York University School of Medicine
² State University of New York–Upstate Medical University
³ Massachusetts General Hospital, Harvard Medical School
⁴ Lilly Research Laboratories
⁵ University of Utah School of Medicine
⁶ Center for Behavioral Genomics

^* To whom correspondence should be addressed. E-mail: Lenard.adler{at}med.nyu.edu.

	Abstract

Objective: Little information is available comparing self- versus investigator ratings of symptoms in adult ADHD. The authors compared the reliability, validity, and utility in a sample of adults with ADHD and also as an index of clinical improvement during treatment of self- and investigator ratings of ADHD symptoms via the Conners Adult ADHD Rating Scale (CAARS). Method: We analyzed data from two double-blind, parallel-design studies of 536 adult ADHD patients, randomized to 10-week treatment with atomoxetine or placebo. Outcome variables included ADHD symptom severity (CAARS self- and investigator ratings), psychiatric symptom comorbidity, and functioning. Results: All five CAARS sub-scales showed good internal consistency at each time point. Similarly, interrater reliability was acceptable for each subscale. Following treatment, CAARS total scores and subscale scores improved significantly from baseline. CAARS subscales also predicted changes in other psychiatric symptoms and functioning. Overall, baseline investigator ratings were stronger predictors of treatment outcome than baseline self-report scores. Conclusions: The CAARS demonstrated good internal consistency and inter-rater reliability, as well as sensitivity to treatment outcome. The finding of greater predictive power of investigator-rated baseline scores merits further investigation. (J. of Att. Dis. 2008; XX(X) xx-xx)

First published on November 19, 2007, doi:10.1177/1087054707308503

Journal of Attention Disorders 2008;11:711.

A more recent version of this article appeared on May 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?